Skip to content
Trial Eligibility
Menu

RaDIANT Health Systems Intervention

NCT07033117

This study is recruiting at 5 US sites in 4 states, according to its ClinicalTrials.gov record last updated .

Summary

The overarching goal of the proposed study is to determine whether the addition of structural interventions at the health system level targeting upstream barriers in the transplant process will improve access to transplant evaluation start.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • End Stage Renal Disease (ESRD)
  • Kidney Disease

Eligibility basics and study details

Study type
Interventional
Phase
Not applicable
Ages
18 to 80 years
Sex
All
Healthy volunteers
Accepted
Sponsor
Indiana University
Last updated on ClinicalTrials.gov
May 26, 2026

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

Georgia · 2

  • Emory Transplant Center · Atlanta, GA
  • Piedmont Transplant Institute · Atlanta, GA

Indiana · 1

  • IU Health Transplant - Indianapolis · Indianapolis, IN

North Carolina · 1

  • Duke Transplant Center · Durham, NC

South Carolina · 1

  • MUSC Mid-Carolinas Transplant Center · Lancaster, SC

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.